Project Grant R61NS149098
Award Date 8/20/26
Completion Date 5/31/28
Dollars Obligated $715K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
East Lansing, MI 48824, USA
Similar Awards
- The National Institute of Neurological Disorders and Stroke awarded Regents of the University of Michigan $128,358 on February 16, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to explore cholinergic brain activity changes and their associations with sleep alterations in Lewy body disease. The research investigates how cholinergic neurotransmission affects the sleep-wake cycle, particularly rapid eye movement (REM) sleep...
- The National Institute on Aging awarded Michigan State University (doing business as Henry Ford Health+Michigan State University Health Sciences) $624,029 on September 1, 2026, for research into dimensional complexity as a biomarker for cognitive resilience in aging and dementia under the Aging Research program (CFDA 93.866). The project will develop and clinically validate dimensional complexity (DC), a novel resting-state fMRI biomarker that quantifies dynamic brain activity organization, to...
- The National Institute on Aging awarded Michigan State University (doing business as Henry Ford Health+Michigan State University Health Sciences) $314,000 on April 1, 2026, under the Aging Research program (CFDA 93.866) to optimize and validate detection and modeling of the vascular and glymphatic systems in cerebral waste clearance using superparamagnetic iron oxide-enhanced susceptibility weighted imaging (SPIO-SWI), and to investigate cerebral waste clearance changes during Alzheimer's...
- This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, provides $2,234,905.00 in funding to The University of Iowa to support research aimed at understanding the underlying mechanisms responsible for cognitive fluctuations in Lewy body disorders (LBD). The project will use mouse models to evaluate how the accumulation of...
- This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under CFDA Program 93.853 - Extramural Research Programs in the Neurosciences and Neurological Disorders, will provide $2,280,379 to the Regents of the University of Michigan to develop novel nanobody-based agents that can target pathogenic alpha-synuclein to block its cell-to-cell transmission. The grant aims to characterize these nanobody-based agents and assess their in vitro and in...
- The National Institute of Neurological Disorders and Stroke awarded The Leland Stanford Junior University a cooperative agreement of $4,161,896 on August 1, 2026, to conduct a Phase 2 double-blind placebo-controlled clinical trial evaluating the safety and efficacy of donanemab in 400 participants with dementia with Lewy bodies plus Alzheimer's disease (DLB+AD). The award funds the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The trial...
- The National Institute of Neurological Disorders and Stroke awarded the University of Alabama at Birmingham $499,648 on September 1, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to investigate heparan sulfate-mediated mechanisms of alpha-synuclein pathology in dementia with Lewy bodies disease. The project examines how heparan sulfate proteoglycans promote the neuronal internalization of alpha-synuclein fibrils, a pathological...
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded Henry Ford Health + Michigan State University Health Sciences a project grant of $431,750 under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) for research investigating a novel therapeutic strategy to treat multi-infarct dementia (MID). The award, effective May 20, 2025, through April 30, 2027, funds preclinical research utilizing...
- The National Institute of Neurological Disorders and Stroke awarded Regents of the University of Michigan $619,212 on July 6, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The award funds transcriptomics research on blood samples in amyotrophic lateral sclerosis (ALS) to advance diagnosis, prognosis, drug discovery, and identification of molecular disease subtypes. The research addresses delayed ALS diagnosis (typically over a...
- The National Institute of Neurological Disorders and Stroke awarded Cleveland Clinic Lerner College of Medicine of Case Western Reserve University $432,711 on September 1, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to investigate mitochondrial gasdermin-D propagation of neuroinflammation and neurodegeneration in alpha-synucleinopathy. The research examines mechanisms by which alpha-synuclein aggregates trigger...